We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

44 hedge funds and large institutions have $15.8M invested in Anixa Biosciences in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $65K | Put options by funds: $32K

3% more capital invested

Capital invested by funds: $15.4M → $15.8M (+$394K)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

0.01% less ownership

Funds ownership: 11.86% → 11.85% (-0.01%)

10% less funds holding

Funds holding: 49 → 44 (-5)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
9
Closed
6
Calls
$65K
Puts
$32K
Net Calls
+$33K
Net Calls Change
-$136K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$371K
2
Jane Street
Jane Street
New York
+$271K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$136K
4
Stifel Financial
Stifel Financial
Missouri
+$87.6K
5
VF
Virtu Financial
New York
+$80.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$205K
2
Citadel Advisors
Citadel Advisors
Florida
-$159K
3
Renaissance Technologies
Renaissance Technologies
New York
-$116K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$96.5K
5
CAM
Concorde Asset Management
Michigan
-$65.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
26
Simplicity Solutions
Minnesota
$66.6K +$67.8K +15,481 New
BRWA
27
B. Riley Wealth Advisors
Florida
$65.4K – – –
IAIM
28
International Assets Investment Management
Florida
$62.4K +$15.3K +3,500 +32%
Charles Schwab
29
Charles Schwab
California
$55K – – –
NFG
30
Nations Financial Group
Iowa
$49.5K -$6.57K -1,500 -12%
Citadel Advisors
31
Citadel Advisors
Florida
$48.2K -$159K -36,292 -76%
ATC
32
Adirondack Trust Company
New York
$30K – – –
JP Morgan Chase
33
JP Morgan Chase
New York
$24.5K +$21.9K +5,000 +769%
TWM
34
Tradition Wealth Management
Minnesota
$22K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$14K +$14K +3,190 +1,571%
AA
36
Ancora Advisors
Ohio
$6.54K – – –
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$4K – – –
Wells Fargo
38
Wells Fargo
California
$3.07K -$4.36K -995 -58%
ASN
39
Advisory Services Network
Georgia
$2.9K – – –
LFG
40
Larson Financial Group
Missouri
$2.26K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$1.72K -$2.19K -500 -56%
US Bancorp
42
US Bancorp
Minnesota
$1.72K – – –
BC
43
Barrett & Company
Rhode Island
$344 – – –
TAM
44
Tucker Asset Management
Colorado
$43 – – –
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
– -$96.5K -22,712 Closed
CAM
46
Concorde Asset Management
Michigan
– -$65.9K -15,500 Closed
First Manhattan
47
First Manhattan
New York
– -$27.6K -6,500 Closed
FWA
48
Freedom Wealth Alliance
Wisconsin
– -$23.2K -5,453 Closed
SWM
49
Spire Wealth Management
Virginia
– -$11K -2,500 Closed
Carson Wealth (CWM LLC)
50
Carson Wealth (CWM LLC)
Nebraska
– -$1K -250 Closed
1
2

ANIX Hedge Fund Activity: Q1 2023 in Review

44 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2023, worth a combined $15.8M — up 2.6% from $15.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ANIX and 3 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Susquehanna International Group, adding an estimated $371K. The largest seller was BlackRock, cutting an estimated $205K.

  • 44 institutional investors held Anixa Biosciences (ANIX) as of Q1 2023, down from 49 in Q4 2022.
  • Funds reported $15.8M of Anixa Biosciences stock for Q1 2023, up 2.6% quarter-over-quarter.
  • 3 funds opened new Anixa Biosciences positions in Q1 2023 and 6 closed out, a net change of -3 holders.
  • The largest Anixa Biosciences buyer in Q1 2023 was Susquehanna International Group, an estimated $371K added.
  • The largest Anixa Biosciences seller in Q1 2023 was BlackRock, an estimated $205K sold.

Based on aggregated 13F filings for Q1 2023.